Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: July 24, 2023
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
Journal: American journal of hematology
Published: April 26, 2023
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
Journal: Blood cancer journal
Published: March 01, 2023
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
Journal: British journal of haematology
Published: December 30, 2022
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
Journal: Transplantation and cellular therapy
Published: November 29, 2022
Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: a narrative review of clinical trials.
Journal: Stem cell investigation
Published: October 14, 2022
Association of medical uninsurance with sociodemographic attributes in US cancer population: A cross-sectional study of NHANES data 2013 to 2018.
Journal: Medicine
Published: October 05, 2022
Treatment of Light Chain Deposition Disease: A Systematic Review.
Journal: Journal of hematology
Published: July 23, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: June 24, 2022
Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 09, 2022
Durable remission of acute myeloid leukemia in an elderly patient following a limited course of azacitidine and venetoclax.
Journal: Leukemia research reports
Published: June 03, 2022
Last Updated: 09/26/2026